Entirely Health

NOTTINGHAMSHIRE HEALTH NEWS

Friday March 22 2019


Senior appointments enhance Sygnature Discoverys DMPK capabilities




Senior appointments enhance Sygnature Discoverys DMPK capabilities

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has recruited four key individuals to boost its DMPK (drug metabolism and pharmacokinetics) capabilities. Dr Stuart Best, Dr Hayley Butler, Dr Daniel Weston and Dr Bodo Spöri have all joined the senior management team of the company’s DMPK department.

Dr Stuart Best joins as Associate Director of DMPK and will manage and supervise the growth of the Alderley Park-based part of the DMPK team, which opened in 2018. Stuart has more than 25 years’ experience in the pharmaceutical industry, working in regulatory bioanalysis and drug discovery. He joins from RedX Pharma, where he established and developed the company’s analytical and DMPK capabilities. In addition, Dr Warren Keene is relocating to Alderley Park from Sygnature’s Nottingham headquarters to assist Stuart in the management of the facility.

Dr Hayley Butler joins Sygnature Discovery as a principal scientist. In her previous role at RedX Pharma, she worked on oncology and infection projects, and brings significant project management and PK/PD expertise to the team.

To reinforce Sygnature’s capabilities in metabolism studies, Dr Daniel Weston has been recruited as an Associate Director. He will be based in Nottingham, and provides significant analytical, mass spectrometry and biotransformation expertise gained at various biotech and large pharma companies. Most recently, Daniel was responsible for integrated biotransformation support to the respiratory and oncology therapeutic areas at AstraZeneca. This included the de-risking of human safety and metabolic liabilities, and novel approaches to human ADME (absorption, distribution, metabolism and excretion) studies.

Finally, Dr Bodo Spöri has joined the company as Senior Director of Business Development for Sygnature’s DMPK services. After several years in academia, Bodo has spent 15 years in various business development roles, both European and global, recently at Cyprotex and Domainex. His experience spans ADME-Toxicology/DMPK, as well as biology, chemistry and integrated projects.

Sygnature Discovery’s expansion into Alderley Park was announced in summer 2018. The purpose-built facility opened in October 2018 and has a team of highly-experienced scientists working on a wide variety of DMPK projects on behalf of clients.

Director of DMPK Dr Tim Schultz-Utermoehl commented: "I am very pleased with how the DMPK department is growing in Nottingham and Alderley Park. We have a great mix of pharma industry veterans and up-and-coming scientists, all highly-qualified and from a variety of backgrounds. Stuart, Hayley, Daniel and Bodo add considerable experience and expertise, further enriching the senior management team within Sygnature’s DMPK Department."

Senior Vice President of Business Development, Dr Paul Clewlow added: "Demand for Sygnature’s DMPK services and expertise is growing year-on-year, and following our expansion into Alderley Park last year, we have additional space to continue to grow the company. It is significant that we have been able to attract expert DMPK scientists into Sygnature with experience from other disciplines. Their broad range of drug discovery know-how facilitates the collaborative nature of client projects, who come to Sygnature because we are able to offer a high quality fully-integrated drug discovery service, but we also have the flexibility to provide DMPK, medicinal chemistry and in vitro pharmacology as stand-alone services."

For further information, visit: www.sygnaturediscovery.com or email: a.lindstrom@sygnaturediscovery.com



"Demand for Sygnatures DMPK services and expertise is growing year-on-year, and following our expansion into Alderley Park last year, we have additional space to continue to grow the company. "
Dr Paul Clewlow








DISCLAIMER: The statements, opinions, views and advice expressed in this article are those of the author/organisation and not of ENTIRELY. This article should represent information correct at the time of publication however whilst every care has been taken to present up-to-date and accurate information, we cannot guarantee that inaccuracies will not occur. ENTIRELY will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within this article or any information accessed through this site. The content of any organisations websites which you link to from ENTIRELY are entirely out of the control of ENTIRELY, and you proceed at your own risk. These links are provided purely for your convenience and do not imply any endorsement of or association with any products, services, content, information or materials offered by or accessible to you at the organisations site.






RECOMMENDED FOR YOU ON ENTIRELY MIDLANDS






















































Discover our Industry Magazines
















Discover our UK Regional Magazines


North West Business News, Jobs and Events | Entirely North West UK
East of England Business News, Jobs and Events | Entirely East England UK
Ireland Business News, Jobs and Events | Entirely Ireland
London Business News, Jobs and Events | Entirely London UK
Midlands Business News, Jobs and Events | Entirely Midlands UK
North East Business News, Jobs and Events | Entirely North East UK
Scotland Business News, Jobs and Events | Entirely Scotland
South East Business News, Jobs and Events | Entirely South East UK
South West Business News, Jobs and Events | Entirely South West UK
Wales Business News, Jobs and Events | Entirely Wales
Yorkshire Business News, Jobs and Events | Entirely Yorkshire UK